EVOLVE BIOLOGICS Trademark

Trademark Overview


On Tuesday, December 12, 2017, a trademark application was filed for EVOLVE BIOLOGICS with the United States Patent and Trademark Office. The USPTO has given the EVOLVE BIOLOGICS trademark a serial number of 87717949. The federal status of this trademark filing is REGISTERED as of Tuesday, March 23, 2021. This trademark is owned by Therapure Biopharma Inc.. The EVOLVE BIOLOGICS trademark is filed in the Pharmaceutical Products, Construction & Repair Services, Treatment & Processing of Materials Services, Education & Entertainment Services, and Computer & Software Services & Scientific Services categories with the following description:

Biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for human clinical use, namely, plasma protein fractions, serum albumin, immunoglobulins, coagulation factors, antihemophilic factors, clotting factors, enzymes, coenzymes, coactivators, inhibitors, and structural proteins; resins, for medical use, namely, polysaccharide beads cross-linked to ligands for capturing proteins from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate using chromatographic methods

Construction of biotech, biopharmaceutical and plasma manufacturing facilities relevant to the manufacturing of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate; consulting services concerning construction of biotech; Consulting services concerning building construction of biotech facilities

Contract manufacturing services for others for biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development, and clinical use; consulting services concerning manufacturing of biologics

Educational services, namely, designing, arranging, and conducting training programs for research and development, manufacturing of biologics, design, construction, and use of chromatography equipment

Development of pharmaceutical preparations and medicines, namely, development services for others for the capture of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development; consulting services for others concerning the capture of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development, design and construction of chromatography equipment, and design of biotech, biopharmaceutical and plasma manufacturing facilities, namely, scientific research and evaluation, and engineering; Design of biotech, biopharmaceutical and plasma manufacturing facilities relevant to the manufacturing of biolotics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate
evolve biologics

General Information


Serial Number87717949
Word MarkEVOLVE BIOLOGICS
Filing DateTuesday, December 12, 2017
Status700 - REGISTERED
Status DateTuesday, March 23, 2021
Registration Number6297748
Registration DateTuesday, March 23, 2021
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, January 5, 2021

Trademark Statements


Certificate of Correction for RegistrationIn the statement, page 2, line 9, "EVLOVE" should be deleted, and "EVOLVE" should be inserted.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"BIOLOGICS"
Description of MarkThe mark consists of the word "EVOLVE" in stylized lettering with the "V" forming into the "O" with the word "BIOLOGICS" underneath the letters "LVE" in stylized format.
Goods and ServicesBiologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for human clinical use, namely, plasma protein fractions, serum albumin, immunoglobulins, coagulation factors, antihemophilic factors, clotting factors, enzymes, coenzymes, coactivators, inhibitors, and structural proteins; resins, for medical use, namely, polysaccharide beads cross-linked to ligands for capturing proteins from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate using chromatographic methods
Goods and ServicesConstruction of biotech, biopharmaceutical and plasma manufacturing facilities relevant to the manufacturing of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate; consulting services concerning construction of biotech; Consulting services concerning building construction of biotech facilities
Goods and ServicesContract manufacturing services for others for biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development, and clinical use; consulting services concerning manufacturing of biologics
Goods and ServicesEducational services, namely, designing, arranging, and conducting training programs for research and development, manufacturing of biologics, design, construction, and use of chromatography equipment
Goods and ServicesDevelopment of pharmaceutical preparations and medicines, namely, development services for others for the capture of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development; consulting services for others concerning the capture of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development, design and construction of chromatography equipment, and design of biotech, biopharmaceutical and plasma manufacturing facilities, namely, scientific research and evaluation, and engineering; Design of biotech, biopharmaceutical and plasma manufacturing facilities relevant to the manufacturing of biolotics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 22, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class037 - Building construction; repair; installation services.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateFriday, December 22, 2017
Primary Code037
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateFriday, December 22, 2017
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateFriday, December 22, 2017
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 22, 2017
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEVOLVE BIOLOGICS INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMississauga, Ontario L5N 8G6
CA

Party NameTherapure Biopharma Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMississauga, Ontario L5N8H9
CA

Party NameTherapure Biopharma Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMississauga, Ontario L5N8H9
CA

Trademark Events


Event DateEvent Description
Wednesday, July 7, 2021REVIEW OF CORRESPONDENCE COMPLETE - INFORMATION MADE OF RECORD
Wednesday, July 7, 2021CORRECTION UNDER SECTION 7 ¿ PROCESSED
Thursday, July 1, 2021TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, April 19, 2021TEAS SECTION 7 REQUEST RECEIVED
Tuesday, March 23, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, January 5, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 5, 2021PUBLISHED FOR OPPOSITION
Wednesday, December 16, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 1, 2020LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, November 26, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 25, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 25, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 25, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 6, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 6, 2020NON-FINAL ACTION E-MAILED
Monday, July 6, 2020NON-FINAL ACTION WRITTEN
Thursday, June 25, 2020LETTER OF PROTEST EVIDENCE FORWARDED
Wednesday, February 12, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 12, 2020NON-FINAL ACTION E-MAILED
Wednesday, February 12, 2020NON-FINAL ACTION WRITTEN
Tuesday, January 28, 2020PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, January 14, 2020WITHDRAWN FROM PUB - OG REVIEW QUERY
Wednesday, January 1, 2020ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, December 30, 2019ELECTRONIC RECORD REVIEW COMPLETE
Friday, December 27, 2019ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Thursday, December 19, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 18, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 18, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 13, 2019TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, November 27, 2019ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, October 30, 2019ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, June 19, 2019NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, June 19, 2019INQUIRY TO SUSPENSION E-MAILED
Wednesday, June 19, 2019SUSPENSION INQUIRY WRITTEN
Friday, November 30, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, November 30, 2018LETTER OF SUSPENSION E-MAILED
Friday, November 30, 2018SUSPENSION LETTER WRITTEN
Wednesday, November 7, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 7, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 30, 2018TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, May 3, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, May 3, 2018LETTER OF SUSPENSION E-MAILED
Thursday, May 3, 2018SUSPENSION LETTER WRITTEN
Thursday, May 3, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 3, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 1, 2018ASSIGNED TO LIE
Tuesday, April 24, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 16, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 16, 2018NON-FINAL ACTION E-MAILED
Friday, February 16, 2018NON-FINAL ACTION WRITTEN
Wednesday, February 14, 2018ASSIGNED TO EXAMINER
Friday, December 22, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, December 15, 2017NEW APPLICATION ENTERED IN TRAM